EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study

Ida Gruber, Barbara Kollerits, Lukas Forer, Silvia Di Maio, Johanna F Schachtl-Riess, Azin Kheirkhah, Sebastian Schönherr, Ulla T Schultheiss, Anna Köttgen, Kai-Uwe Eckardt, Stefan Coassin, Claudia Lamina und 1 weitere

Journal of Internal Medicine · 2024-12 · 296 (6) · 510-526

DOI: 10.1111/joim.20027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 08.11.2024. Verfasst von Ida Gruber und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Lipoprotein(a), Renal Insufficiency, Chronic, Cardiovascular Diseases, Glomerular Filtration Rate. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, German Ministry of Education and Research, KfH Foundation for Preventive Medicine, Innovative Medicines Initiative 2 Joint Undertaking.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein(a) (Lp(a)) is a causal, genetically determined risk factor for cardiovascular disease (CVD) in the general population. Patients with chronic kidney disease (CKD) have an increased CVD risk and elevated Lp(a) concentrations. Only a few studies on Lp(a) were performed in persons with mild‐to‐moderate CKD; none of them used genetic variants to explore potential causal associations.

Objectives

This study aims to investigate the association of measured and genetically predicted Lp(a) concentrations on prevalent and incident CVD events in the German Chronic Kidney Disease (GCKD) study.

Methods

The study included 5043 participants of European ancestry with an estimated glomerular filtration rate (eGFR) between 30 and 60 mL/min/1.73 m 2 or an eGFR >60 mL/min/1.73 m 2 in the presence of overt albuminuria with a follow‐up of 6.5 years.

Results

With each 10 mg/dL higher Lp(a) concentration, odds for prevalent CVD (1290 events) increased 1.065‐fold (95%CI: 1.042–1.088, p < 0.001). The risk was significantly higher in patients with Lp(a) ≥50 mg/dL but most pronounced in Lp(a) ≥70 mg/dL (odds ratio = 1.775 [1.409–2.231], p < 0.001) compared to Lp(a)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Renal Insufficiency, ChronicCardiovascular DiseasesGlomerular Filtration RateHumansMaleFemaleMiddle AgedGermanyAgedRisk FactorsPrevalenceIncidence

Stichwörter der Autor:innen

German Chronic Kidney Disease studycardiovascular diseasechronic kidney diseaselipoprotein(a)

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Faculty of Medicine and Medical Center, Institute of Genetic Epidemiology, University of Freiburg, Freiburg, Germany.
  • Department of Medicine IV, Nephrology and Primary Care, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Synlab MVZ Humangenetik Freiburg GmbH, Freiburg, Germany.
  • Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Florian Kronenberg

Förderung

  • Austrian Science Fund
  • German Ministry of Education and Research
  • KfH Foundation for Preventive Medicine, Innovative Medicines Initiative 2 Joint Undertaking
  • Deutsche Forschungsgemeinschaft CRC

Zitieren

APA

Gruber, I., Kollerits, B., Forer, L., Di Maio, S., Schachtl-Riess, J. F., Kheirkhah, A., Schönherr, S., Schultheiss, U. T., Köttgen, A., Eckardt, K. U., Coassin, S., Lamina, C., & Kronenberg, F. (2024). Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study. Journal of Internal Medicine, 296(6), 510-526. https://doi.org/10.1111/joim.20027

Vancouver

Gruber I, Kollerits B, Forer L, Di Maio S, Schachtl-Riess JF, Kheirkhah A, et al. Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study. Journal of Internal Medicine. 2024;296(6):510-526. doi:10.1111/joim.20027

BibTeX
@article{Gruber2024,
  author = {Gruber, Ida and Kollerits, Barbara and Forer, Lukas and Di Maio, Silvia and Schachtl-Riess, Johanna F and Kheirkhah, Azin and Schönherr, Sebastian and Schultheiss, Ulla T and Köttgen, Anna and Eckardt, Kai-Uwe and Coassin, Stefan and Lamina, Claudia and Kronenberg, Florian},
  title = {Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study},
  journal = {Journal of Internal Medicine},
  year = {2024},
  volume = {296},
  number = {6},
  pages = {510--526},
  doi = {10.1111/joim.20027}
}
Kostenlos starten →